2po7 Citations

Altered orientation of active site residues in variants of human ferrochelatase. Evidence for a hydrogen bond network involved in catalysis.

Biochemistry 46 7973-9 (2007)
Related entries: 1hrk, 2pnj, 2po5

Cited: 20 times
EuropePMC logo PMID: 17567154

Abstract

Ferrochelatase catalyzes the terminal step in heme biosynthesis, the insertion of ferrous iron into protoporphyrin to form protoheme IX. The crystal structures of human ferrochelatase both with and without the protoporphyrin substrate bound have been determined previously. The substrate-free enzyme has an open active site pocket, while in the substrate-bound enzyme, the active site pocket is closed around the porphyrin macrocycle and a number of active site residues have reoriented side chains. To understand how and why these structural changes occur, we have substituted three amino acid residues (H263, H341, and F337) whose side chains occupy different spatial positions in the substrate-free versus substrate-bound ferrochelatases. The catalytic and structural properties of ferrochelatases containing the amino acid substitutions H263C, H341C, and F337A were examined. It was found that in the H263C and H341C variants, but not the F337A variant enzymes, the side chains of N75, M76, R164, H263, F337, H341, and E343 are oriented in a fashion similar to what is found in ferrochelatase with the bound porphyrin substrate. However, all of the variant forms possess open active site pockets which are found in the structure of porphyrin-free ferrochelatase. Thus, while the interior walls of the active site pocket are remodeled in these variants, the exterior lips remain unaltered in position. One possible explanation for this collective reorganization of active site side chains is the presence of a hydrogen bond network among H263, H341, and E343. This network is disrupted in the variants by alteration of H263C or H341C. In the substrate-bound enzyme, the formation of a hydrogen bond between H263 and a pyrrole nitrogen results in disruption of the network. The possible role of this network in catalysis is discussed.

Articles - 2po7 mentioned but not cited (3)

  1. Altered orientation of active site residues in variants of human ferrochelatase. Evidence for a hydrogen bond network involved in catalysis. Dailey HA, Wu CK, Horanyi P, Medlock AE, Najahi-Missaoui W, Burden AE, Dailey TA, Rose J. Biochemistry 46 7973-7979 (2007)
  2. A conserved amphipathic ligand binding region influences k-path-dependent activity of cytochrome C oxidase. Hiser C, Buhrow L, Liu J, Kuhn L, Ferguson-Miller S. Biochemistry 52 1385-1396 (2013)
  3. AI-driven pan-proteome analyses reveal insights into the biohydrometallurgical properties of Acidithiobacillia. Li L, Zhou L, Jiang C, Liu Z, Meng D, Luo F, He Q, Yin H. Front Microbiol 14 1243987 (2023)


Reviews citing this publication (6)

  1. One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans. Hamza I, Dailey HA. Biochim Biophys Acta 1823 1617-1632 (2012)
  2. Prokaryotic Heme Biosynthesis: Multiple Pathways to a Common Essential Product. Dailey HA, Dailey TA, Gerdes S, Jahn D, Jahn M, O'Brian MR, Warren MJ. Microbiol Mol Biol Rev 81 e00048-16 (2017)
  3. Metal trafficking: from maintaining the metal homeostasis to future drug design. Ba LA, Doering M, Burkholz T, Jacob C. Metallomics 1 292-311 (2009)
  4. Heme biosynthesis and its regulation: towards understanding and improvement of heme biosynthesis in filamentous fungi. Franken AC, Lokman BC, Ram AF, Punt PJ, van den Hondel CA, de Weert S. Appl Microbiol Biotechnol 91 447-460 (2011)
  5. HemQ: An iron-coproporphyrin oxidative decarboxylase for protoheme synthesis in Firmicutes and Actinobacteria. Dailey HA, Gerdes S. Arch Biochem Biophys 574 27-35 (2015)
  6. Ferrochelatase: Mapping the Intersection of Iron and Porphyrin Metabolism in the Mitochondria. Obi CD, Bhuiyan T, Dailey HA, Medlock AE. Front Cell Dev Biol 10 894591 (2022)

Articles citing this publication (11)

  1. A pi-helix switch selective for porphyrin deprotonation and product release in human ferrochelatase. Medlock AE, Dailey TA, Ross TA, Dailey HA, Lanzilotta WN. J Mol Biol 373 1006-1016 (2007)
  2. Product release rather than chelation determines metal specificity for ferrochelatase. Medlock AE, Carter M, Dailey TA, Dailey HA, Lanzilotta WN. J Mol Biol 393 308-319 (2009)
  3. Chemistry and Molecular Dynamics Simulations of Heme b-HemQ and Coproheme-HemQ. Hofbauer S, Dalla Sega M, Scheiblbrandner S, Jandova Z, Schaffner I, Mlynek G, Djinović-Carugo K, Battistuzzi G, Furtmüller PG, Oostenbrink C, Obinger C. Biochemistry 55 5398-5412 (2016)
  4. The antenna-like domain of the cyanobacterial ferrochelatase can bind chlorophyll and carotenoids in an energy-dissipative configuration. Pazderník M, Mareš J, Pilný J, Sobotka R. J Biol Chem 294 11131-11143 (2019)
  5. Mitochondrial contact site and cristae organizing system (MICOS) machinery supports heme biosynthesis by enabling optimal performance of ferrochelatase. Dietz JV, Willoughby MM, Piel RB, Ross TA, Bohovych I, Addis HG, Fox JL, Lanzilotta WN, Dailey HA, Wohlschlegel JA, Reddi AR, Medlock AE, Khalimonchuk O. Redox Biol 46 102125 (2021)
  6. Identification and characterization of solvent-filled channels in human ferrochelatase. Medlock AE, Najahi-Missaoui W, Ross TA, Dailey TA, Burch J, O'Brien JR, Lanzilotta WN, Dailey HA. Biochemistry 51 5422-5433 (2012)
  7. FERROCHELATASE: THE CONVERGENCE OF THE PORPHYRIN BIOSYNTHESIS AND IRON TRANSPORT PATHWAYS. Hunter GA, Al-Karadaghi S, Ferreira GC. J Porphyr Phthalocyanines 15 350-356 (2011)
  8. Investigation by MD simulation of the key residues related to substrate-binding and heme-release in human ferrochelatase. Wang Y, Wu J, Ju J, Shen Y. J Mol Model 19 2509-2518 (2013)
  9. Protonation of guanine quartets and quartet stacks: insights from DFT studies. Liu H, Gauld JW. Phys Chem Chem Phys 11 278-287 (2009)
  10. Insight into the function of active site residues in the catalytic mechanism of human ferrochelatase. Medlock AE, Najahi-Missaoui W, Shiferaw MT, Albetel AN, Lanzilotta WN, Dailey HA. Biochem J 478 3239-3252 (2021)
  11. Molecular dynamics simulations of mouse ferrochelatase variants: what distorts and orientates the porphyrin? Szefczyk B, Cordeiro MN, Franco R, Gomes JA. J Biol Inorg Chem 14 1119-1128 (2009)


Related citations provided by authors (2)

  1. The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis.. Wu CK, Dailey HA, Rose JP, Burden A, Sellers VM, Wang BC Nat Struct Biol 8 156-60 (2001)
  2. Human ferrochelatase: crystallization, characterization of the [2Fe-2S] cluster and determination that the enzyme is a homodimer.. Burden AE, Wu C, Dailey TA, Busch JL, Dhawan IK, Rose JP, Wang B, Dailey HA Biochim Biophys Acta 1435 191-7 (1999)